Urinary biomarkers in septic acute kidney injury.

Sean M Bagshaw, Christoph Langenberg, Michael Haase, Li Wan, Clive N May, Rinaldo Bellomo
Author Information
  1. Sean M Bagshaw: Division of Critical Care Medicine, University of Alberta Hospital, 3C1.16 Walter C. Mackenzie Centre, 8440-112 Street, T6G 2B7, Edmonton, Alberta, Canada. bagshaw@ualberta.ca.
  2. Christoph Langenberg: Department of Intensive Care Medicine, Austin Hospital, Studley Road, 3084, Heidelberg, VIC, Australia.
  3. Michael Haase: Department of Intensive Care Medicine, Austin Hospital, Studley Road, 3084, Heidelberg, VIC, Australia.
  4. Li Wan: Department of Intensive Care Medicine, Austin Hospital, Studley Road, 3084, Heidelberg, VIC, Australia.
  5. Clive N May: Howard Florey Institute, University of Melbourne, 161 Barry Street, 3053, South Carlton, VIC, Australia.
  6. Rinaldo Bellomo: Department of Intensive Care Medicine, Austin Hospital, Studley Road, 3084, Heidelberg, VIC, Australia.

Abstract

OBJECTIVE: To appraise the literature on the value of urinary biomarkers in septic acute kidney injury (AKI).
DESIGN: Systematic review.
SETTING: Academic medical centre.
PATIENTS AND PARTICIPANTS: Human studies of urinary biomarkers.
INTERVENTIONS: None.
MEASUREMENTS AND RESULTS: Fourteen articles fulfilled inclusion criteria. Most studies were small, single-centre, and included mixed medical/surgical adult populations. Few focused solely on septic AKI and all had notable limitations. Retrieved articles included data on low-molecular-weight proteins (beta2-microglobulin, alpha1-microglobulin, adenosine deaminase binding protein, retinol binding protein, cystatin C, renal tubular epithelial antigen-1), enzymes (N-acetyl-beta-glucosaminidase, alanine-aminopeptidase, alkaline phosphatase; lactate dehydrogenase, alpha/pi-glutathione-S-transferase, gamma-glutamyl transpeptidase), cytokines [platelet activating factor (PAF), interleukin-18 (IL-18)] and other biomarkers [kidney injury molecule-1, Na/H exchanger isoform-3 (NHE3)]. Increased PAF, IL-18, and NHE3 were detected early in septic AKI and preceded overt kidney failure. Several additional biomarkers were evident early in AKI; however, their diagnostic value in sepsis remains unknown. In one study, IL-18 excretion was higher in septic than in non-septic AKI. IL-18 also predicted deterioration in kidney function, with increased values preceding clinically significant kidney failure by 24-48 h. Detection of cystatin C, alpha1-microglobulin, and IL-18 predicted need for renal replacement therapy (RRT).
CONCLUSIONS: Few clinical studies of urinary biomarkers in AKI have included septic patients. However, there is promising evidence that selected biomarkers may aid in the early detection of AKI in sepsis and may have value for predicting subsequent deterioration in kidney function. Additional prospective studies are needed to accurately describe their diagnostic and prognostic value in septic AKI.

References

  1. Crit Care. 2005 Aug;9(4):R363-74 [PMID: 16137349]
  2. Indian Pediatr. 1997 Feb;34(2):107-11 [PMID: 9255003]
  3. Lancet. 2005 Apr 2-8;365(9466):1231-8 [PMID: 15811456]
  4. J Am Soc Nephrol. 2003 Apr;14(4):1022-30 [PMID: 12660337]
  5. Chest. 1990 Jul;98(1):170-9 [PMID: 2361386]
  6. J Biol Chem. 1998 Feb 13;273(7):4135-42 [PMID: 9461608]
  7. Am J Kidney Dis. 2004 Mar;43(3):405-14 [PMID: 14981598]
  8. Crit Care Med. 2001 Oct;29(10):1910-5 [PMID: 11588450]
  9. Kidney Int. 2002 Jul;62(1):237-44 [PMID: 12081583]
  10. Intensive Care Med. 1999 Aug;25(8):814-21 [PMID: 10447538]
  11. Am J Transplant. 2004 Mar;4(3):432-7 [PMID: 14961998]
  12. Kidney Int. 2002 Nov;62(5):1601-10 [PMID: 12371960]
  13. Nephrol Dial Transplant. 1987;2(3):143-8 [PMID: 2888057]
  14. Curr Opin Crit Care. 2004 Dec;10 (6):476-82 [PMID: 15616389]
  15. Am J Physiol Renal Physiol. 2006 Feb;290(2):F517-29 [PMID: 16174863]
  16. Monatsschr Kinderheilkd. 1993 Jan;141(1):59-69 [PMID: 8446119]
  17. Ann Clin Biochem. 2004 Mar;41(Pt 2):111-8 [PMID: 15025800]
  18. N Engl J Med. 2001 Mar 29;344(13):947-54 [PMID: 11274620]
  19. Crit Care. 2005;9(6):R700-9 [PMID: 16280066]
  20. Am J Kidney Dis. 2003 Sep;42(3):497-506 [PMID: 12955677]
  21. J Clin Invest. 2002 Oct;110(8):1083-91 [PMID: 12393844]
  22. Intensive Care Med. 1999 Aug;25(8):805-13 [PMID: 10447537]
  23. Curr Opin Crit Care. 2003 Dec;9(6):496-502 [PMID: 14639069]
  24. Gastroenterology. 1982 Jan;82(1):97-105 [PMID: 6171479]
  25. Clin Chem. 1986 Mar;32(3):529-32 [PMID: 2868815]
  26. Crit Care. 2005 Aug;9(4):R294-302 [PMID: 16137340]
  27. Nephron. 1980;26(1):7-12 [PMID: 7393380]
  28. Pediatr Nephrol. 1995 Aug;9(4):419-22 [PMID: 7577399]
  29. Nephrol Dial Transplant. 1993;8(6):507-11 [PMID: 8394530]
  30. Kidney Int. 2006 Jul;70(1):199-203 [PMID: 16710348]
  31. Crit Care Med. 2002 Oct;30(10):2205-11 [PMID: 12394945]
  32. Am J Respir Crit Care Med. 2000 Jul;162(1):191-6 [PMID: 10903628]
  33. J Clin Invest. 2001 May;107(9):1145-52 [PMID: 11342578]
  34. J Am Soc Nephrol. 2003 Oct;14 (10 ):2534-43 [PMID: 14514731]
  35. Crit Care. 2006;10(3):R73 [PMID: 16696865]
  36. Nephrol Dial Transplant. 2003 Mar;18(3):543-51 [PMID: 12584277]
  37. Am J Physiol Renal Physiol. 2003 May;284(5):F1046-55 [PMID: 12554636]
  38. Surg Forum. 1972;23(0):51-3 [PMID: 4671024]
  39. Shock. 2006 Sep;26(3):245-53 [PMID: 16912649]
  40. J Am Soc Nephrol. 2005 Oct;16(10):3046-52 [PMID: 16148039]
  41. Nephrol Dial Transplant. 2006 Dec;21(12):3389-97 [PMID: 16998215]
  42. Nephrol Dial Transplant. 1996 Feb;11(2):293-9 [PMID: 8700363]
  43. Intensive Care Med. 2004 Jan;30(1):33-7 [PMID: 14618231]
  44. Am J Physiol Renal Physiol. 2004 Mar;286(3):F552-63 [PMID: 14600030]
  45. JAMA. 2005 Aug 17;294(7):813-8 [PMID: 16106006]
  46. Am J Nephrol. 2004 May-Jun;24(3):307-15 [PMID: 15148457]
  47. Clin Chem. 2004 Mar;50(3):552-8 [PMID: 14709451]
  48. Kidney Int. 2006 Jun;69(11):1996-2002 [PMID: 16641923]
  49. Pediatr Infect Dis J. 1988 Feb;7(2):142-3 [PMID: 2894005]
  50. Curr Opin Nephrol Hypertens. 1998 Nov;7(6):681-5 [PMID: 9864665]
  51. Am J Kidney Dis. 2004 May;43(5):817-24 [PMID: 15112172]
  52. Transplantation. 1986 May;41(5):593-7 [PMID: 2871646]
  53. Nephrol Dial Transplant. 1999 May;14(5):1150-7 [PMID: 10344354]
  54. J Lab Clin Med. 1989 Mar;113(3):316-24 [PMID: 2538527]

MeSH Term

Acute Disease
Biomarkers
Cytokines
Enzymes
Humans
Proteinuria
Renal Insufficiency
Sepsis

Chemicals

Biomarkers
Cytokines
Enzymes

Word Cloud

Created with Highcharts 10.0.0AKIbiomarkersseptickidneyIL-18valuestudiesurinaryinjuryincludedearlyacuteANDarticlesalpha1-microglobulinbindingproteincystatinCrenalPAF]NHE3failurediagnosticsepsispredicteddeteriorationfunctionmayOBJECTIVE:appraiseliteratureDESIGN:SystematicreviewSETTING:AcademicmedicalcentrePATIENTSPARTICIPANTS:HumanINTERVENTIONS:NoneMEASUREMENTSRESULTS:Fourteenfulfilledinclusioncriteriasmallsingle-centremixedmedical/surgicaladultpopulationsfocusedsolelynotablelimitationsRetrieveddatalow-molecular-weightproteinsbeta2-microglobulinadenosinedeaminaseretinoltubularepithelialantigen-1enzymesN-acetyl-beta-glucosaminidasealanine-aminopeptidasealkalinephosphataselactatedehydrogenasealpha/pi-glutathione-S-transferasegamma-glutamyltranspeptidasecytokines[plateletactivatingfactorinterleukin-18[kidneymolecule-1Na/Hexchangerisoform-3IncreaseddetectedprecededovertSeveraladditionalevidenthoweverremainsunknownonestudyexcretionhighernon-septicalsoincreasedvaluesprecedingclinicallysignificant24-48hDetectionneedreplacementtherapyRRTCONCLUSIONS:clinicalpatientsHoweverpromisingevidenceselectedaiddetectionpredictingsubsequentAdditionalprospectiveneededaccuratelydescribeprognosticUrinary

Similar Articles

Cited By (46)